Virus Filtration Market to Grow at CAGR of 8.67% through 2030

Rising demand for single-use virus filtration systems and expansion of virus filtration in gene and cell therapy manufacturing is expected to drive the Global Virus Filtration Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “Virus Filtration Market – Global Industry Size, Share, Trends, Competition, Forecast & Opportunities, 2020-2030F”, the Global Virus Filtration Market stood at USD 5.31 Billion in 2024 and is expected to reach USD 7.41 Billion by 2030 with a CAGR of 8.67% during the forecast period.

Automation and digitalization are revolutionizing the virus filtration market by enhancing process efficiency, data integrity, and regulatory compliance. The adoption of real-time monitoring systems, process analytical technology (PAT), and automated virus filtration platforms is helping biopharmaceutical manufacturers streamline workflows and minimize manual intervention. These technologies enable continuous monitoring of critical parameters such as pressure differentials, flow rates, and membrane integrity, ensuring consistent filtration performance and reducing batch-to-batch variability. The integration of Industry 4.0 technologies, including artificial intelligence (AI), machine learning, and cloud-based data analytics, is further optimizing virus filtration efficiency. AI-powered predictive maintenance tools analyze historical filtration data to detect early signs of membrane fouling or performance degradation, allowing manufacturers to address issues proactively and minimize production downtime.Digital twin technology is being explored to create virtual models of virus filtration processes, enabling biopharmaceutical firms to simulate and optimize filtration parameters before full-scale implementation. Regulatory agencies are increasingly encouraging the adoption of digital solutions to enhance transparency and traceability in manufacturing. Companies are leveraging electronic batch records (EBRs), automated compliance tracking, and blockchain-based documentation to ensure adherence to Good Manufacturing Practices (GMP) and regulatory guidelines. As the demand for biopharmaceuticals continues to grow, the combination of automation, AI-driven analytics, and digital monitoring solutions will drive significant advancements in virus filtration efficiency, scalability, and cost-effectiveness.

The rapid advancements in gene and cell therapy manufacturing have intensified the need for sophisticated virus filtration solutions to ensure product safety and regulatory compliance. Gene and cell therapy products often involve the use of viral vectors for gene delivery, increasing the risk of viral contamination during manufacturing. As a result, regulatory agencies such as the FDA and EMA have imposed stringent biosafety guidelines, necessitating the implementation of robust virus filtration strategies. Unlike traditional biologics, gene and cell therapies require highly specialized filtration technologies due to their unique characteristics, such as small batch sizes, high-value products, and sensitivity to processing conditions. To address these challenges, manufacturers are developing virus-retentive filters with enhanced selectivity, minimal protein binding, and improved retention efficiency to maximize therapeutic yield. Advancements in nanofiltration and depth filtration techniques are enabling the removal of viral contaminants while preserving the structural integrity of cell-based therapies. The increasing pipeline of gene and cell therapy products, including CAR-T cell therapies and mRNA-based vaccines, is expected to further drive innovation in virus filtration. As personalized medicine continues to gain traction, virus filtration technologies must evolve to accommodate the complex purification requirements of next-generation biologics. Industry stakeholders are investing in tailored filtration solutions, modular manufacturing platforms, and advanced analytical tools to enhance process reliability and scalability. The expansion of virus filtration in gene and cell therapy manufacturing represents a critical growth area within the broader biopharmaceutical industry.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Virus Filtration Market”

The Global Virus Filtration Market is segmented into product, technology, end use, regional distribution, and company.

Based on the product category, Consumables was the fastest-growing segment in the global Virus Filtration market in 2024. Consumables play a crucial role in the biopharmaceutical manufacturing process, being used in large quantities and often as single-use items, creating a constant and growing demand. The stringent regulatory requirements for virus filtration require high-quality consumables to ensure safety and compliance, leading to increased investment in products that meet these industry standards. Ongoing research and development efforts have resulted in innovative consumables that improve filtration efficiency, reduce costs, and enhance product yield, driving the rapid growth of this segment. Additionally, the consumables segment offers cost-effective solutions, enabling the biopharmaceutical industry to reduce production costs while maintaining product quality. The application of virus filtration spans beyond pharmaceuticals, extending into industries such as food and beverage, biotechnology, and water purification, contributing to the expansion of the consumables market.

Based on region, Europe stands as the second most dominating region in the global virus filtration market, driven by its well-established biopharmaceutical industry, stringent regulatory landscape, and increasing investments in biologics manufacturing. The region is home to several leading biopharmaceutical and biotechnology firms, including Roche, Novartis, and Sanofi, which rely extensively on virus filtration technologies to ensure product safety and regulatory compliance. The European Medicines Agency (EMA) enforces rigorous guidelines for virus clearance in biologics production, compelling manufacturers to adopt advanced virus filtration solutions. The growing demand for monoclonal antibodies, gene therapies, and vaccines has fueled the need for high-efficiency virus filtration systems. Countries such as Germany, Switzerland, and the United Kingdom have emerged as key hubs for biologics manufacturing and research, further propelling market growth.

Europe is also witnessing an increase in contract development and manufacturing organizations (CDMOs), which cater to the expanding biopharmaceutical sector by offering virus filtration-integrated production services. The region's strong focus on biosimilars and personalized medicine enhances the adoption of virus filtration in small-batch biologics production. Advancements in automation, real-time monitoring, and high-capacity filtration technologies are further strengthening Europe’s position in the market.

Major companies operating in Global Virus Filtration Market are:

• Merck KGaA
• Danaher Corporation
• Sartorius AG
• Thermo Fisher Scientific Inc.
• GE Healthcare Technologies, Inc.
• Charles River Laboratories
• Asahi Kasei Medical Co., Ltd.
• WuXi AppTec
• Lonza Group AG
• Clean Biologics

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The increasing global demand for biologics, including monoclonal antibodies, recombinant proteins, and vaccines, has fueled the adoption of high-capacity virus filtration systems designed for large-scale manufacturing. Traditional virus filtration processes often encounter challenges such as membrane clogging, reduced flow rates, and prolonged processing times, leading to inefficiencies in high-volume production. To address these limitations, manufacturers are developing advanced virus-retentive filters with enhanced porosity, greater filtration capacity, and improved flow dynamics. Hybrid filtration membranes, which combine depth filtration and size-exclusion mechanisms, are emerging as a promising solution to enhance virus removal efficiency while maintaining high protein recovery rates. The industry is shifting toward modular filtration systems that integrate multiple purification steps into a single unit, reducing operational complexity and improving process efficiency. The transition to continuous bioprocessing has further accelerated the demand for high-capacity virus filtration solutions, as continuous manufacturing enables seamless integration of upstream and downstream purification workflows. Companies are also exploring novel filtration materials, such as high-performance polymer membranes and nanostructured surfaces, to improve virus retention and extend filter lifespan. As biopharmaceutical manufacturers scale up their production capacities to meet increasing global demand, virus filtration technologies must evolve to support high-throughput operations while ensuring consistent product safety and efficacy. The development of next-generation virus filtration systems with enhanced scalability, automation, and real-time monitoring capabilities will be instrumental in meeting the growing needs of the biopharmaceutical industry.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Virus Filtration Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Consumables {Kits and reagents, Others}, Instruments (Filtration systems, Chromatography systems), Services), By Technology (Filtration, Chromatography), By End Use (Biopharmaceutical & biotechnology companies, Contract research organizations, Academic institutes & research laboratories, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Virus Filtration Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Virus Filtration Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com